SJOGREN'S SYNDROME (SS)
Clinical trials for SJOGREN'S SYNDROME (SS) explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME (SS) trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME (SS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial offers hope for kids with tough autoimmune diseases
Disease control Not yet recruitingThis early-stage study will test a new cell therapy called YTS109 in 12 children aged 5 to 17 with severe autoimmune diseases like lupus and scleroderma that haven't responded to other treatments. The goal is to see if the therapy is safe and can help control the disease. Childre…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New CAR-Treg therapy aims to tame autoimmune attacks
Disease control Not yet recruitingThis early-stage study tests a new treatment called BEN301 for people with autoimmune diseases like scleroderma, rheumatoid arthritis, Sjogren's syndrome, and inflammatory muscle diseases. The therapy uses specially engineered immune cells (CAR-Tregs) to calm the overactive immun…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC